Insider · CIK 0001415245

Cameron Tammy

Reports to the SEC for 1 company · MENLO PARK, CA

sec.gov

Transactions

Companies

Filings

CIK

0001415245

Forms 4 and 5

Insider transactions

23 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2011-09-01	Assertio Therapeutics, IncStock optionA Award	VP, Finance	AAward	+37.5K sh	—	—	37,500
2011-06-14	Assertio Therapeutics, IncS Sale	VP, Finance	SSale	−6,579 sh	$8.24	−$54.2K	3,960
2011-06-14	Assertio Therapeutics, IncM Exercise/Conversion	VP, Finance	MExercise/Conversion	+1,354 sh	$1.83	+$2,477.82	5,314
2011-06-14	Assertio Therapeutics, IncS Sale	VP, Finance	SSale	−1,354 sh	$8.20	−$11.1K	3,960
2011-06-14	Assertio Therapeutics, IncM Exercise/Conversion	VP, Finance	MExercise/Conversion	+4,487 sh	$3.09	+$13.9K	8,447
2011-06-14	Assertio Therapeutics, IncS Sale	VP, Finance	SSale	−4,487 sh	$8.20	−$36.8K	3,960
2011-06-14	Assertio Therapeutics, IncM Exercise/Conversion	VP, Finance	MExercise/Conversion	+17.5K sh	$3.09	+$54.1K	21,453
2011-06-14	Assertio Therapeutics, IncS Sale	VP, Finance	SSale	−17.5K sh	$8.20	−$143K	3,960
2011-06-14	Assertio Therapeutics, IncStock OptionM Exercise/Conversion	VP, Finance	MExercise/Conversion	−1,354 sh	—	—	27,083
2011-06-14	Assertio Therapeutics, IncStock OptionM Exercise/Conversion	VP, Finance	MExercise/Conversion	−17.5K sh	—	—	31,898
2011-06-14	Assertio Therapeutics, IncStock OptionM Exercise/Conversion	VP, Finance	MExercise/Conversion	−4,487 sh	—	—	16,122
2011-05-12	Assertio Therapeutics, IncStock OptionM Exercise/Conversion	VP, Finance	MExercise/Conversion	−18.8K sh	—	—	28,437
2011-05-12	Assertio Therapeutics, IncM Exercise/Conversion	VP, Finance	MExercise/Conversion	+18.8K sh	$1.83	+$34.4K	28,875
2011-05-12	Assertio Therapeutics, IncS Sale	VP, Finance	SSale	−18.8K sh	$8.26	−$155K	10,054
2011-05-11	Assertio Therapeutics, IncStock OptionM Exercise/Conversion	VP, Finance	MExercise/Conversion	−30K sh	—	—	0
2011-05-11	Assertio Therapeutics, IncM Exercise/Conversion	VP, Finance	MExercise/Conversion	+17.7K sh	$1.83	+$32.5K	27,796
2011-05-11	Assertio Therapeutics, IncS Sale	VP, Finance	SSale	−17.7K sh	$8.36	−$148K	10,054
2011-05-11	Assertio Therapeutics, IncS Sale	VP, Finance	SSale	−30K sh	$8.61	−$258K	10,054
2011-05-11	Assertio Therapeutics, IncStock OptionM Exercise/Conversion	VP, Finance	MExercise/Conversion	−17.7K sh	—	—	47,258
2011-05-11	Assertio Therapeutics, IncM Exercise/Conversion	VP, Finance	MExercise/Conversion	+30K sh	$1.98	+$59.4K	40,054
2011-01-14	Assertio Therapeutics, IncStock optionA Award	VP, Finance	AAward	+32.5K sh	—	—	32,500
2010-01-07	Assertio Therapeutics, IncStock optionA Award	VP, Finance	AAward	+70K sh	—	—	70,000
2009-01-23	Assertio Therapeutics, IncStock OptionA Award	VP, Finance	AAward	+65K sh	—	—	65,000

Recent filings

Accepted (ET)
Sep 24
Cameron Tammy0001179110-11-012906
SEC(opens sec.gov)
Jun 154
Cameron Tammy0001179110-11-009693
SEC(opens sec.gov)
May 134
Cameron Tammy0001179110-11-007981
SEC(opens sec.gov)

Companies

Assertio Therapeutics, IncVP, Finance

Address

1360 O'BRIEN DR.

MENLO PARK, CA, 94025